These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9708759)

  • 21. Genetic polymorphism of methylenetetrahydrofolate reductase and venous thromboembolism: a case-control study.
    González Ordóñez AJ; Fernández Alvarez CR; Rodríguez JM; García EC; Alvarez MV
    Haematologica; 1999 Feb; 84(2):190-1. PubMed ID: 10091425
    [No Abstract]   [Full Text] [Related]  

  • 22. [The relationship between the mutation of methylenetetrahydrofolate reductase gene 677C-->T and the diabetic microangiopathy].
    Hu S; Gan P; Li J; Bi H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr; 18(2):118-21. PubMed ID: 11295130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MTHFR gene polymorphism as a risk factor for diabetic retinopathy in type 2 diabetic patients without serum creatinine elevation.
    Maeda M; Yamamoto I; Fukuda M; Nishida M; Fujitsu J; Nonen S; Igarashi T; Motomura T; Inaba M; Fujio Y; Azuma J
    Diabetes Care; 2003 Feb; 26(2):547-8. PubMed ID: 12547903
    [No Abstract]   [Full Text] [Related]  

  • 24. Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy.
    Poirier LA; Brown AT; Fink LM; Wise CK; Randolph CJ; Delongchamp RR; Fonseca VA
    Metabolism; 2001 Sep; 50(9):1014-8. PubMed ID: 11555831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between MTHFR gene polymorphisms, plasma homocysteine levels and diabetic retinopathy in type 2 diabetes mellitus.
    Sun J; Xu Y; Zhu Y; Lu H; Deng H; Fan Y; Sun S; Zhang Y
    Chin Med J (Engl); 2003 Jan; 116(1):145-7. PubMed ID: 12667409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
    Ksiazek P; Bednarek-Skublewska A; Buraczyńska M
    Med Sci Monit; 2004 Feb; 10(2):BR47-51. PubMed ID: 14737040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylenetetrahydrofolate reductase polymorphism, type II diabetes mellitus, coronary artery disease, and essential hypertension in the Czech population.
    Benes P; Kanková K; Muzík J; Groch L; Benedík J; Elbl L; Izakovicová-Hollá L; Vasků A; Znojil V; Vácha J
    Mol Genet Metab; 2001 Jun; 73(2):188-95. PubMed ID: 11386855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylenetetrahydrofolate reductase (MTHFR). Incidence of the C677T mutation in a Siberian female population.
    Belkovets AV; Kurilovich SA; Agarwal DP
    Anthropol Anz; 2001 Mar; 59(1):19-25. PubMed ID: 11360806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy.
    Sacchi E; Tagliabue L; Duca F; Mannucci PM
    Thromb Haemost; 1997 Aug; 78(2):963-4. PubMed ID: 9268207
    [No Abstract]   [Full Text] [Related]  

  • 30. Is there a role for genetic polymorphism of C677T methylenetetrahydrofolate reductase (MTHFR) in Buerger's disease?
    Kawasaki T; Fujimura H; Kakinoki E; Uemichi A; Miyata T
    Thromb Haemost; 2000 Oct; 84(4):736-7. PubMed ID: 11057887
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between methylenetetrahydrofolate reductase (MTHFR) A1298C gene polymorphism and type 2 diabetic nephropathy risk: a meta-analysis.
    Zhang J; Xiao Y; Zhang XW; Gao ZQ; Han JH
    Ren Fail; 2014 Jul; 36(6):974-8. PubMed ID: 24678913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Eroglu Z; Erdogan M; Tetik A; Karadeniz M; Cetinalp S; Kosova B; Gunduz C; Ozgen AG; Yilmaz C
    Diabetes Metab Res Rev; 2007 Nov; 23(8):621-4. PubMed ID: 17354258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic predisposition for development of nephropathy in type 2 diabetes mellitus.
    Kumar R; Sharma RK; Agarwal S
    Biochem Genet; 2013 Dec; 51(11-12):865-75. PubMed ID: 23846111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma homocysteine and microvascular complications in type 1 diabetes.
    Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients.
    Brulhart MC; Dussoix P; Ruiz J; Passa P; Froguel P; James RW
    Am J Hum Genet; 1997 Jan; 60(1):228-9. PubMed ID: 8981966
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of association between carotid intima-media thickness and methylenetetrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin-dependent diabetes mellitus.
    Mazza A; Motti C; Nulli A; Marra G; Gnasso A; Pastore A; Federici G; Cortese C
    Metabolism; 2000 Jun; 49(6):718-23. PubMed ID: 10877195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphism of catalase gene promoter in Romanian patients with diabetic kidney disease and type 1 diabetes.
    Panduru NM; Moţa E; Moţa M; Cimponeriu D; Serafinceanu C; Cheţa DM
    Rom J Intern Med; 2010; 48(1):81-8. PubMed ID: 21180245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylene tetrahydrofolate reductase gene and coronary artery disease.
    Iqbal MP; Frossard PM
    J Pak Med Assoc; 2003 Jan; 53(1):33-6. PubMed ID: 12666851
    [No Abstract]   [Full Text] [Related]  

  • 39. The association between end-stage diabetic nephropathy and methylenetetrahydrofolate reductase genotype with macroangiopathy in type 2 diabetes mellitus.
    Hasegawa G; Obayashi H; Kamiuchi K; Nakai M; Kanatsuna T; Yamaguchi M; Tanaka T; Shigeta H; Fujii M; Yoshikawa T; Nakamura N
    Exp Clin Endocrinol Diabetes; 2003 May; 111(3):132-8. PubMed ID: 12784186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to "genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A".
    Isotalo PA; Donnelly JG
    Am J Med Genet; 2002 Jun; 110(2):191-2. PubMed ID: 12116261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.